Geriatric Cancer

Allison J. Applebaum, PhD, will lead the new Center for Caregiving at Mount Sinai.

Research has insufficiently addressed the intersection of aging, health disparities and cancer outcomes among older adults, according to study findings published in Journal of the American Geriatrics Society.

William Dale, MD, PhD, FASCO, has experienced a range of emotions since learning he’d receive the B.J. Kennedy Geriatric Oncology Award at this year’s ASCO Annual Meeting.

Polypharmacy and potential drug-drug interactions appeared associated with increased risk for adverse treatment outcomes among older adults with advanced cancer, according to a secondary analysis of the GAP70+ trial published in Cancer.

Unsupervised machine learning helped identify older adults with advanced cancer who appeared more likely to experience unplanned hospitalization and death, according to study results published in JAMA Network Open.

Researchers identified substantial racial and ethnic disparities in access to prescription opioids among older patients with cancer nearing end of life, according to study results published in Journal of Clinical Oncology.

Cancer is a disease that disproportionately affects the elderly, and current guidelines recommend a comprehensive geriatric assessment for older patients with cancer.

Adults aged older than 70 years expressed the same level of interest in participating in cancer clinical trials as younger adults, according to study results in a research letter published in JAMA Network Open.

Bladder cancer disproportionately affects older individuals, with diagnosis occurring at a median age of 73 years.

Gerontology researchers and hematologic oncology investigators from Brigham and Women’s Hospital and Dana-Farber Cancer Institute have devised a scale for assessing high-risk medications in older patients with blood cancers.